Vorinostat breast anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells K562 Cells HL-60 Cells Cell Line Mammary Glands, Human HCT116 Cells Milk, Human HT29 Cells Mitochondria

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases34

Radiation Injuries Carcinoma, Ductal, Breast Breast Diseases Neoplasms Breast Neoplasms, Male Radiation Injuries, Experimental Neoplasms, Radiation-Induced Radiation Pneumonitis Fibrocystic Breast Disease Lymphoma, T-Cell, Cutaneous Breast Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Brain Neoplasms Colonic Neoplasms Lung Neoplasms Adenocarcinoma Carcinoma Carcinoma, Intraductal, Noninfiltrating Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Carcinoma, Lobular Lymphatic Metastasis Acute Radiation Syndrome Ovarian Neoplasms Neoplasms, Experimental Glioblastoma Radiodermatitis Leukemia Glioma Disease Progression Breast Cyst Neovascularization, Pathologic Skin Neoplasms

Chemicals and Drugs91

Hydroxamic Acids Antineoplastic Agents Histone Deacetylase Inhibitors Doxorubicin Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Radiation-Sensitizing Agents Cisplatin Neoplasm Proteins Receptors, Estrogen Histone Deacetylases Drug Carriers Enzyme Inhibitors Boronic Acids Etoposide Pyrazines Paclitaxel Fluorouracil Receptor, erbB-2 Tumor Markers, Biological Ellipticines Tamoxifen Benzenesulfonates P-Glycoprotein Tumor Suppressor Protein p53 Camptothecin Receptors, Progesterone Proto-Oncogene Proteins c-bcl-2 RNA, Messenger Niacinamide Phenylurea Compounds DNA Topoisomerases, Type II Radiation-Protective Agents Histones Depsipeptides Prodrugs Protein Kinase Inhibitors Plant Extracts Cyclin-Dependent Kinase Inhibitor p21 Apoptosis Regulatory Proteins RNA, Small Interfering DNA, Neoplasm Antineoplastic Agents, Hormonal Topoisomerase I Inhibitors Antimetabolites, Antineoplastic Daunorubicin DNA Caspases HSP90 Heat-Shock Proteins Aurora Kinase A Piperazines Mitoxantrone Proteasome Inhibitors Platinum Myeloid Cell Leukemia Sequence 1 Protein Nanocapsules Taxoids Caspase 3 Cobalt Radioisotopes Antineoplastic Agents, Alkylating Flavonoids Anticarcinogenic Agents Antibodies, Monoclonal, Humanized Reactive Oxygen Species Protein-Serine-Threonine Kinases DNA-Binding Proteins Carboplatin Organoplatinum Compounds Vinblastine DNA Adducts Cell Cycle Proteins Pyridines Mitomycin ATP-Binding Cassette Transporters Cyclophosphamide Multidrug Resistance-Associated Proteins Inhibitor of Apoptosis Proteins Antibodies, Monoclonal Pyrimidines Doxepin Drugs, Investigational Intercalating Agents Tumor Suppressor Proteins Proto-Oncogene Proteins Estrogen Receptor alpha Estrogens Topoisomerase II Inhibitors Xanthones bcl-2-Associated X Protein Adjuvants, Pharmaceutic Bleomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Radiation Dosage Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Xenograft Model Antitumor Assays Antineoplastic Combined Chemotherapy Protocols Drug Delivery Systems Radiation Injuries, Experimental Radiotherapy Mammography Drug Carriers Treatment Outcome Prognosis Combined Modality Therapy Radiotherapy Dosage Blotting, Western Breast Implants Tumor Stem Cell Assay Neoplasm Staging Radiometry Inhibitory Concentration 50 Clinical Trials, Phase I as Topic Gene Expression Profiling Breast Self-Examination Drug Evaluation, Preclinical Tumor Burden Maximum Tolerated Dose Immunohistochemistry Mastectomy Neoplasm Transplantation Drug Design Reverse Transcriptase Polymerase Chain Reaction Disease-Free Survival Models, Biological Transplantation, Heterologous Mammary Neoplasms, Experimental Risk Factors Mastectomy, Segmental Radiotherapy, Adjuvant Chemotherapy, Adjuvant Molecular Targeted Therapy Ultrasonography, Mammary Survival Analysis Case-Control Studies Follow-Up Studies Survival Rate Administration, Oral Neoplasms, Experimental Radiotherapy, Conformal Transfection Nanocapsules Clinical Trials as Topic Drug Discovery Mammaplasty Retrospective Studies Dose Fractionation Oligonucleotide Array Sequence Analysis Radiation Hybrid Mapping Brachytherapy Drug Administration Schedule Radiotherapy, Intensity-Modulated Immunoblotting Radiotherapy Planning, Computer-Assisted Sensitivity and Specificity Flow Cytometry Reproducibility of Results

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes49

Radiation, Ionizing Radiation Dosage Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Drug Resistance, Neoplasm Drug Synergism Cell Proliferation Gene Expression Regulation, Neoplastic Cell Survival Breast Feeding DNA Damage Dose-Response Relationship, Drug Cell Cycle Acetylation Cosmic Radiation Gamma Rays Time Factors Background Radiation Signal Transduction Ultraviolet Rays Drug Resistance, Multiple Inhibitory Concentration 50 Molecular Structure Maximum Tolerated Dose DNA Repair Cell Cycle Checkpoints Radiation Effects Cell Death Cell Division Down-Regulation Mutation G2 Phase X-Rays Transfection Genes, BRCA1 Up-Regulation Tissue Distribution DNA Adducts Phosphorylation Base Sequence Postmenopause Drug Resistance Structure-Activity Relationship Autophagy Cell Growth Processes Sensitivity and Specificity Genes, MDR

Disciplines and Occupations6

Radiation Oncology Immunohistochemistry Drug Design Nanomedicine Drug Discovery Radiobiology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Milk, Human

Information Science6

Survival Rate Radiotherapy, Conformal Molecular Sequence Data Base Sequence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Health Care24

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Treatment Outcome Ultraviolet Rays Clinical Trials, Phase I as Topic Radiation Effects Disease-Free Survival National Cancer Institute (U.S.)Risk Factors Acute Radiation Syndrome Survival Analysis Case-Control Studies Follow-Up Studies Survival Rate Clinical Trials as Topic Retrospective Studies Radioactive Hazard Release Sensitivity and Specificity Reproducibility of Results

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Hydroxamic Acids Breast Antineoplastic Agents Radiation, Ionizing Radiation Dosage Cell Line, Tumor Histone Deacetylase Inhibitors Radiation Injuries Carcinoma, Ductal, Breast Dose-Response Relationship, Radiation Radiation Tolerance Breast Diseases Drug Screening Assays, Antitumor Neoplasms Radiation Apoptosis Drug Resistance, Neoplasm Radiation Protection Radiation Monitoring Drug Synergism Tumor Cells, Cultured Cell Proliferation Xenograft Model Antitumor Assays Mice, Nude Gene Expression Regulation, Neoplastic Cell Survival Doxorubicin Breast Feeding Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Phytogenic Radiation Oncology Antibiotics, Antineoplastic Radiation-Sensitizing Agents DNA Damage Cisplatin Dose-Response Relationship, Drug Cell Cycle Drug Delivery Systems Acetylation Cosmic Radiation Gamma Rays Neoplasm Proteins Receptors, Estrogen Histone Deacetylases Breast Neoplasms, Male Radiation Injuries, Experimental Radiotherapy Neoplasms, Radiation-Induced Radiation Pneumonitis Mammography Drug Carriers Enzyme Inhibitors Time Factors Boronic Acids Etoposide Pyrazines Paclitaxel Treatment Outcome Fluorouracil Receptor, erbB-2 Tumor Markers, Biological Fibrocystic Breast Disease Prognosis Lymphoma, T-Cell, Cutaneous Background Radiation Ellipticines Combined Modality Therapy Tamoxifen Signal Transduction Radiotherapy Dosage Blotting, Western MCF-7 Cells Breast Implants Tumor Stem Cell Assay Neoplasm Staging Ultraviolet Rays Radiometry Benzenesulfonates Drug Resistance, Multiple P-Glycoprotein Tumor Suppressor Protein p53 Inhibitory Concentration 50 Camptothecin Clinical Trials, Phase I as Topic K562 Cells Gene Expression Profiling Receptors, Progesterone Breast Neoplasms Breast Self-Examination Drug Evaluation, Preclinical Neoplasm Metastasis Proto-Oncogene Proteins c-bcl-2 Tumor Burden Molecular Structure Maximum Tolerated Dose DNA Repair Neoplasm Invasiveness Immunohistochemistry Mastectomy Cell Cycle Checkpoints

No FAQ available that match "vorinostat breast anticancer drugs or radiation"